Profound Medical Corp. PROF
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -69.58% | -22.10% | |||
| Total Other Revenue | -34.84% | 7.47% | |||
| Total Revenue | -53.48% | -10.71% | |||
| Cost of Revenue | -64.39% | -24.22% | |||
| Gross Profit | -49.19% | -3.98% | |||
| SG&A Expenses | 11.65% | -7.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.43% | 0.09% | |||
| Operating Income | -37.96% | -8.85% | |||
| Income Before Tax | -34.96% | 13.76% | |||
| Income Tax Expenses | 120.00% | -3.85% | |||
| Earnings from Continuing Operations | -35.26% | 13.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.26% | 13.72% | |||
| EBIT | -37.96% | -8.85% | |||
| EBITDA | -38.00% | -9.10% | |||
| EPS Basic | -35.05% | 26.98% | |||
| Normalized Basic EPS | -34.79% | 27.02% | |||
| EPS Diluted | -35.05% | 26.98% | |||
| Normalized Diluted EPS | -34.79% | 27.02% | |||
| Average Basic Shares Outstanding | 0.15% | 18.13% | |||
| Average Diluted Shares Outstanding | 0.15% | 18.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||